Join Business Exchange
to access the mostrelevant content for you,
filtered by like-mindedbusiness professionals.
investors won't care much what value was put on daclizumab and the rest of the pipeline. Like Eli Lilly's (NYSE: LLY) Have thoughts on which biotech will be the next to be taken out? Let us know in the comment box below...
to access the most relevant content for you, filtered by like-minded business professionals.
About Business Exchange
Send us Feedback
©2013 Bloomberg L.P. All Rights Reserved.